In particular, G007-LK has greater stability and displays favorable pharmacokinetic properties to inhibit Wnt/β-catenin signaling in APC-mutant CRC xenograft tumors (Tanaka et al., 2017; Katoh, 2018). Here, APC is linked to colorectal carcinoma.